Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

PYPD

PolyPid (PYPD)

PolyPid Ltd
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PYPD
DatumZeitQuelleÜberschriftSymbolFirma
28/05/202422h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PYPDPolyPid Ltd
17/05/202422h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PYPDPolyPid Ltd
08/05/202413h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PYPDPolyPid Ltd
06/03/202422h28Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PYPDPolyPid Ltd
06/03/202422h05Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:PYPDPolyPid Ltd
01/03/202418h19Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PYPDPolyPid Ltd
14/02/202414h16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PYPDPolyPid Ltd
14/02/202413h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PYPDPolyPid Ltd
14/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PYPDPolyPid Ltd
01/02/202423h26Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:PYPDPolyPid Ltd
22/01/202414h00Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PYPDPolyPid Ltd
05/01/202415h28Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PYPDPolyPid Ltd
08/11/202313h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PYPDPolyPid Ltd
07/11/202313h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PYPDPolyPid Ltd
18/10/202323h07AllPennyStocks.comNew Collaboration Could Revolutionize Treatment of Chronic Spinal Cord InjuriesNASDAQ:PYPDPolyPid Ltd
11/10/202313h12Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PYPDPolyPid Ltd
10/10/202322h15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PYPDPolyPid Ltd
10/10/202322h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PYPDPolyPid Ltd
20/09/202323h12Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PYPDPolyPid Ltd
20/09/202315h21Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PYPDPolyPid Ltd
18/09/202314h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PYPDPolyPid Ltd
01/09/202322h02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PYPDPolyPid Ltd
01/09/202322h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PYPDPolyPid Ltd
09/08/202322h02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PYPDPolyPid Ltd
09/08/202313h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PYPDPolyPid Ltd
22/06/202313h12Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PYPDPolyPid Ltd
05/06/202322h07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PYPDPolyPid Ltd
22/05/202315h54Dow Jones NewsFDA Approves PolyPid's Trial Design for D-PLEXNASDAQ:PYPDPolyPid Ltd
17/05/202317h09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PYPDPolyPid Ltd
10/05/202313h06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PYPDPolyPid Ltd
 Showing the most relevant articles for your search:NASDAQ:PYPD